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For in vivo multicolor bioluminescence applications, red and near-infrared sig-
nals are desirable over shorter wavelength signals because they are not as
susceptible to light attenuation by blood and tissue. Herein, we describe
the development of a new click beetle luciferase mutant, CBG2, with a red-
shifted color emission. When paired with NH2-NpLH2 luciferin, CBG2 (l =
660 nm) and CBR2 (l = 730 nm) luciferases can be used for simultaneous
dual-color bioluminescence imaging in deep tissue. Using a spectral unmixing
algorithm tool it is possible to distinguish each spectral contribution. Ulti-
mately, this enzyme pair can expand the near-infrared bioluminescent toolbox
to enable rapid visualization of multiple biological processes in deep tissue
using a single substrate.
INTRODUCTION
Bioluminescence imaging (BLI) has become a highly adopted technique for preclinical and non-invasive
study of biological events in vivo (Kaskova et al., 2016; Mezzanotte et al., 2017). The production of biolumi-
nescence depends on luciferase-enzyme-catalyzed oxidation of a luciferin substrate (Wilson and Hastings,
1998). The use of luciferases emitting photons in the ‘‘bio-optical window’’ (l = 600 nm–800 nm) is highly
recommended to limit light absorption by tissue components in vivo (Jathoul et al., 2014; Smith et al.,
2009). Thus, red-shifted luciferase mutants improve the sensitivity of BLI and allow tracking of single cells
over time in deep tissue (Branchini et al., 2010; Iwano et al., 2018). However, it is still challenging to visualize
multiple biological processes over time in deep tissue because current BLI offerings are limited. In many of
the systems currently used, sequential administration of multiple substrates is required, making interpre-
tation of data challenging (Maguire et al., 2013; Taylor et al., 2018). Previously, we attempted dual-color BLI
using green click beetle (CBG99) and red firefly (PpyRe8) luciferases with D-LH2. However, the signal for
CBG99 was attenuated in deep tissue, resulting in acquisition of predominantly the red contribution
(Mezzanotte et al., 2011).
An ideal approach for deep tissue multicolor BLI would be to utilize a single substrate with two luciferases
emitting spectrally separated signals in the near-IR bio-optical window. Notably, the recent development
of infra-luciferin (iLH2) proved to shift the FLuc mutants to the far-red and near-infrared region of spectrum
(FLuc_green 680 nm and FLuc_red 720 nm) (Jathoul et al., 2014; Branchini et al., 2007). Stowe et al.
demonstrated that engrafted red-CAR T cells can expand and reach the green-Raji B lymphoma when
iLH2 is used in vivo (Stowe et al., 2019). Green and red signals were acquired with a sensitive CCD camera
and quantified using a validated spectral unmixing algorithm as part of the instrument software (Aswendt
et al., 2019; Gammon et al., 2006).
Herein, we introduce a novel click beetle mutant named CBG2. CBG2 paired with NH2-NpLH2 substrate
(l = 660 nm) can be integrated with the near-infrared system CBR2/NH2-NpLH2 (l = 730 nm) (Hall et al.,
2018) for dual-color near-infrared (NIR) BLI in vivo. We demonstrate that it is possible to spectrally resolve
and quantify the bright emissions of CBG2 and CBR2 using a spectral unmixing algorithm. The high solu-
bility and low toxicity associated with the salt form of NH2-NpLH2 luciferin make the system amenable to
in vivo injection, thus expanding the BLI toolbox for measuring multiple biological processes in a single
imaging session using a single luciferase substrate.iScience 24, 101986, January 22, 2021 ª 2020 The Author(s).
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Table 1. Relative light unit (RLU) of CBR2, CBG99, and CBG2 measured with D-LH2 and NH2-NpLH2 in transiently











CBR 0.96 620 26.72 660
CBR2 1.97 620 26.34 730
CBG99 0.83 540 0.58 545
CBG99opt 1.00 550 1.00 545
CBG2 4.38 585 14.72 660





Rational design of CBG2 luciferase and spectral characterization
Color variation in click beetle luciferases can be influenced at the protein level by a small number of amino
acid positions. The best characterized mutants, CBG99, CBR, and CBR2, differ at only nine positions. To
create a luciferase that can produce NIR emission suitable for multiplexing with CBR2 and efficiently utilize
NH2-NpLH2, we chose CBG99 as our starting point. CBG99 was preferred over CBR primarily because of its
narrower spectrum (Figure S1A). We first codon-optimized CBG99 luciferase (CBG99opt) to improve gene
expression and protein levels in mammalian cells. CBG99opt has identical codons to CBR2 except at sites
where there are amino acid differences. We confirmed that CBG99opt produces a spectral peak at 540 nm
when combined with D-LH2 (Xu et al., 2016; Miloud et al., 2007) and a peak at 545 nm when used with NH2-
NpLH2 (Table 1).
Next, we designed a panel of mutants based on the nine amino acid differences between CBG99 and
CBR2. The set included amino acid substitutions in the active site known to red-shift emission of beetle lu-
ciferases (Viviani et al., 2016). The mutant of highest interest that emerged from this analysis, CBG2, differs
by six residues compared with CBG99 and by three residues compared with CBR2. CBG2 was red-shifted
by 75 nm with NH2-NpLH2 (660 nm), when compared with the wild-type CBG99/NH2-NpLH2 (545 nm) (Ta-
ble 1). A summary of the spectral characterization and brightness for the purified luciferase mutants is pre-
sented in Table 1. Residues that differ between CBR2 and CBG2 are highlighted in the structure model
shown in Figure 1A. These residues are mainly located in the luciferin binding pocket of the enzymes
and contribute to substrate affinity and color-shift (Woodroofe et al., 2008). We employed D-LH2 and its
analogs NH2-NpLH2 and AkaLumine-HCl (depicted in Figure 1B) to evaluate the function of the novel
mutant in this study.
Luminescence signals for CBR2 and CBG2 with D-LH2 and NH2-NpLH2 (100 mM) were measured in live cells
and lysates (Figure 1C). With D-LH2 as substrate, CBG2 was 5-fold brighter and red-shifted 40 nm (to
585 nm) relative to both CBG99 and CBG99opt. Interestingly, the specificity of CBG2 in live cells is signif-
icantly higher than both CBG99 and CBG99opt with NH2-NpLH2, producing a 25-fold increase in light
output with a 115 nm red-shift (660 nm). CBR2 luciferase yielded the brightest photon emission when
used with NH2-NpLH2 and a near-infrared peak at 720 nm (Figure 1C). The CBR variant (also giving a
peak at 660 nm) was considered for multiplex BLI, but further investigations in live cells revealed a broad,
more intense spectral profile that significantly overlapped with the CBR2 spectrum (Figure S1A).
Kinetic properties for the mutant luciferases were tested in HEK293T live cells with 1.85 mM of NH2-NpLH2
(Figure 1D). After an initial loss (10-fold) in signal, CBG2 reached steady state after 10 min. The signal
strength for CBR2 was higher compared with CBG2, but its signal duration was longer (Figure 1D). Vmax
and Km parameters of the enzymes with titrated D-LH2 or NH2-NpLH2 can be found in Figure S1B. Lumi-
nescence photon fluxes of HEK cells stably expressing CBG2, Luc2, CBR2, or Akaluc luciferases and their
respective brightness with D-LH2, NH2-NpLH2, and Akalumine-HCl are highlighted in Figure S2A.
We attempted to unmix (i.e., resolve) the spectra of CBG2 and CBR2 with D-LH2 or NH2-NpLH2 using trans-
fected HEK293T cells. When treated with D-LH2, CBG2 cells produced nearly 2-fold higher photon flux
compared with CBR2. Emission peaks for the two systems were separated by 35 nm. This modest separa-
tion, combined with the broad emission spectrum for CBR2, prevented efficient resolution of signals2 iScience 24, 101986, January 22, 2021
Figure 1. Rational design of CBG2 luciferase and spectral characterization
For a Figure360 author presentation of this figure, see https://doi.org/10.1016/j.isci.2020.101986.
(A) Homology models of CBG2 (left) and CBR2 (right) luciferases with bound NH2-NpLH2 substrate, based on firefly
luciferase X-ray structure templates (PDB accession codes 2D1S, 4G36, and 5KYT). Residues that differ between CBG2 and
CBR2 (334, 348, 351) are indicated. Modeling and rendering were performed using Discovery Studio software (BIOVIA).
(B) Chemical structures of D-LH2, NH2-NpLH2, and AkaLumine-HCl substrates.
(C) Bioluminescence intensity (RLUmax) of CBG99, CBG99opt, CBR2, and CBG2 (cell lysates) combined with D-LH2 or NH2-
NpLH2 substrates ( n= 3 samples; error bars represent GSD). The spectra of CBG2/D-LH2 (top panel) and CBG2/NH2-
NpLH2 (bottom panel) are presented as reference points. A summary of spectral peaks of the different combinations is
reported in Table 1.
(D) Kinetics of HEK293T CBG99opt, CBG2, and CBR2 cell lysets treated with NH2-NpLH2.
Bioluminescence emission spectra for lysates containing CBG2 and CBR2 with D-LH2 (E) or NH2-NpLH2 (F). Spectra were
acquired using an IVIS Spectrum with the following settings: FOV C, f/stop=1, medium binning, 30 s exposure time, and a




Article(Figure 1E). In contrast, CBG2 cells treated with NH2-NpLH2 showed a consistent, red-shifted biolumines-
cent spectrum peaking at 660 nm and with a photon emission of 1.2 3 106 ph s1. This allowed enough
spectral separation from the 730 nm peak for CBR2 (Figure 1F). Moreover, we confirmed sufficient spectraliScience 24, 101986, January 22, 2021 3
Figure 2. In vitro kinetics and spectral unmixing of CBG2 and CBR2 luciferases
(A) Live-cell bioluminescence kinetics reported for HEK-CBG2 and HEK-CBR2 with NH2-NpLH2. Imaging was performed
using an IVIS Spectrum with no filters and a 30 s exposure time. Imaging acquisitions were made every 2 min for a total of
15 acquisitions. This experiment was performed in triplicate; error bars represent GSD.
(B) Spectral unmixing of HEK cell expressing CBG2 or CBR2 and mixed in various proportions ranging from 100% to 0% of
the total population. Plate was spectrally imaged using IVIS system. Spectral unmix was produced building a specific
library for each pure luciferase/luciferin BLI and then applied to the mixture.
(C) Normalized bioluminescence spectra generated by the spectral unmixing and revealing the feasibility to efficiently
separate green and red spectra. Spectra were normalized to the peak emission for each Click beetle mutants with each
substrate.
(D) Quantification of the percentage unmixed signals of HEK-CBG2 and HEK-CBR2 with NH2-NpLH2. Unmixed signals
were normalized to 100% cell ratios with p < 0.0001 and F-ratio 30.26 for mean values of HEK-CBG2 group and 31.82 for




Articleseparation when CBR2 and CBG2 were co-transfected HEK cells. Use of the spectral unmixing tool allowed
us to calculate the respective unmixed photon fluxes from cells expressing both luciferases (Figure S2B).
In vitro kinetics and spectral unmixing of CBG2 and CBR2 luciferases
Kinetic profiles forCBG2andCBR2weremeasured in stable luciferase-expressingHEKcells in vitro (Figure 2A).
To validate the spectral unmixing of HEK-CBG2 and HEK-CBR2 signals, cells expressing either CBG2 or CBR2
wereplated in various ratios (ranging from100% to 0%) in 96-well blackplates (Figure 2B). Spectral imaging and
unmixing were performed by selecting 14 band pass filters ranging from 540 to 800 nm on the IVIS spectrum
using NH2-NpLH2 as substrate (1 mM). Interestingly, the algorithm was able to measure pure green signals
(100%CBG2) and pure red signals (100%CBR2), making it possible to build a specific library for each luciferase
contribution. The library was then applied to spectral unmixing. Figure 2C shows the successful unmixing of
each spectrum, which then allowed us to plot the normalized and partially overlapped spectra of CBG2
(blue line) and CBR2 (red line). The same library was also used to quantify the photon flux of mixed green
and red cell populations at different percentages between 100% and 0% (Figure 2D).
In vivo characterization of CBG2 and CBR2 mutants and spectral unmixing
To validate the potentiality of the dual-color BLI system in deep tissue, we first injected HEK-CBG2 or HEK-
CBR2 to build a guided library for pure green or red signals. Images were captured using an IVIS imager
with 15 band pass filters ranging from 540 to 800 nm. Pure HEK-CBG2 and HEK-CBR2 or a mixture of the4 iScience 24, 101986, January 22, 2021
Figure 3. In vivo characterization of CBG2 and CBR2 mutants and spectral unmixing
(A) Representative unmixed bioluminescence images of CBG2 and CBR2 with NH2-NpLH2 in deep tissue. Representative
images of mice injected with different cell ratios of HEK-CBG2 and HEK-CBR2 with NH2-NpLH2 in a lung model (n = 3
samples). HEK-CBG2 or HEK-CBR2 cells were injected (I)v. at different proportions and NH2-NpLH2 substrate was
injected (I)p. Images were acquired 15 min after substrate injection. Acquisition time for each filter was of 30 s. Band pass
filters selected were between 540 nm and 800 nm. Filters selected for the green spectral unmixing is at 680 nm and for the
red spectral unmixing is at 720 nm. Images were recorded 15 min after substrate injection considering the enzyme
kinetics. Composite images indicate the linearity between the percentage of cells and the photons emitted.
(B) Spectral proprieties HEK-CBG2 and HEK-CBR2 with NH2-NpLH2.
(C) Quantification of the photon fluxes of the different percentages of HEK-CBG2/NH2-NpLH2 and HEK-CBR2/NH2-
NpLH2 ranged from 100% to 0% as shown in Figure 3A. Bioluminescent unmixed signals were normalized to 100% cell
ratios (n = 3 samples) with p < 0.05, F-ratio 4.064 for mean values of HEK-CBG2 group, and 16.33 for mean values of HEK-




Articletwo cell types was injected following the schema: 100%‒0%; 75%‒25%; and 50%‒50% of green-red and then
the same for red-green. NH2-NpLH2 substrate was injected intraperitoneally and photons flux was recorded
10 min after substrate injection. The spectral unmixing algorithm efficiently extracted green or red contribu-
tions at the different percentages (Figure 3A). Notably, unmixing was also successful when 25% of the total
population of the unmixed green was injected. Quantitative analysis for the unmixed green and the unmixed
red photon fluxes for each cell percentage (0%–25%; 50%–75%; 100%) was performed using Living Image soft-
ware.. Figures 3B and 3C reveals a linear correlation between the percentage of cells injected and photons
recorded for both HEK-CBG2 and HEK-CBR2.Versatility of CBG2 luciferase combined with AkaBLI system for dual color imaging
We further explored whether CBG2/NH2-NpLH2 could be combined with Akaluc/AkaLumine-HCl (Iwano
et al., 2018) for dual-color BLI. We selected two filters: 700 nm for CBG2/NH2-NpLH2 and 660 nm for Aka-
luc/AkaLumine-HCl. Akaluc yielded the brightest photon emission with AkaLumine-HCl (20-fold higher
than CBG2/AkaLumine-HCl, Figure 4A). When the filter was set at 700 nm, CBG2/NH2-NpLH2 was 40-
fold higher than Akaluc/NH2-NpLH2. Interestingly, the pairings CBG2/Akalumine-HCl and Akaluc/NH2-
NpLH2 both recorded a dim signal, suggesting low enzyme activity for these combinations (Figure 4A).
Thus, for dual-color BLI application the use of a single substrate where the enzymes have comparable
expression was not feasible. Spectral curves and respective photon fluxes are depicted in Figure 4B.
Next, we investigated whether a mixture of CBG2 or Akaluc cells could be measured using AkaLumine-
HCl and NH2-NpLH2 for dual-color BLI. First, the original spectrum libraries were efficiently built withiScience 24, 101986, January 22, 2021 5
Figure 4. Versatility of CBG2 luciferase combined with AkaBLI system for dual color imaging
(A) Representative live cell images of HEK-cells expressing Akaluc and CBG2 and tested with AkaLumine-HCl and NH2-
NpLH2. Filters for the spectral unmixing were set at 660 nm for Akaluc/AkaLumine-HCl and at 700 nm for CBG2/NH2-
NpLH2. Plots indicate photon fluxes for in vivo measurements. The experiment was performed in triplicate; error bars
represent GSD.
(B) Spectral properties of HEK-Akaluc and HEK-CBG2 treated with AkaLumine-HCl and NH2-NpLH2 (0.1 mM).
(C) Representative spectral unmixing in vivo (n = 3 samples) for 100%, 50%, or 0% of HEK-CBG2 or HEK-Akaluc with
AkaLumine-HCl or NH2-NpLH2. Cells were injected intravenously and substrates were injected intraperitoneally. Images
were acquired first 15 min after NH2-NpLH2 injection. Then, when pre-scan confirmed the clearance of NH2-NpLH2,
AkaLumine-HCl was injected and images acquired 5 min after substrate injection. Guided libraries were generated to
identify each signal by Living Image software (PerkinElmer). Normalized spectra generated (top-right panel) confirmed
the feasibility to separate CBG2 and Akaluc signals in vivo by selecting filters at 660 nm for Akaluc/AkaLumine-HCl and
700 nm for CBG2/NH2-NpLH2. Acquisition time for each filter was 30 s. Quantification of the photon flux (bottom-right
panel) at the different cell percentages (100%–50%–0%) for HEK-CBG2 or HEK-Akaluc with NH2-NpLH2 and for HEK-




Article100% CBG2 cells or 100% Akaluc cells using Living Image software (PerkinElmer). Each luciferase contribu-
tion was effectively separated and quantified Figure 4C (left). Separation could be achieved when
the luciferase contributions were equal (50% HEK-CBG2 and 50% HEK-Akaluc). The spectral curves and
quantification of luminescence signals at different cell ratios are depicted in Figure 4C (right).
DISCUSSION
We report here on a novel dual NIR click beetle luciferase system that can record semi-quantitative data




Articleand water. Importantly, the administration of NH2-NpLH2 as single substrate provides high sensitivity, re-
duces the number of animals required, and minimizes animal discomfort during the study (Cool et al.,
2013). In comparison to previously published method (Stowe et al., 2019), the brightness of our system
allowed for a substantial reduction in imaging time to 6 min or less (acquisition time per filter of 30 s
instead of 120 s). Similar to previous reports using green luciferases, we observed some attenuation of
CBG2 light emission due to the partial absorbance of the emitted green photons and a shift of the spec-
tral peak to 680‒700 nm in deep tissue (Rumyantsev et al., 2016). However, the spectra of CBG2 and
CBR2 maintained adequate spectral separation in the lungs, which allowed us to distinguish each lucif-
erase contribution.
We also compared the versatility of the new CBG2/NH2-NpLH2 system with the recently developed AKA-
BLI system (650 nm) (Iwano et al., 2018). This method can be exploited for multiplexed bioluminescence
applications where Akaluc/AkaLumine-HCl and CBG2/NH2-NpLH2 can give distinct signals. Indeed, this
setup will effectively probe more than one cellular process, each producing specific BL signals upon
sequential administration of each substrate in vivo. However, this multiplex application will be less spe-
cific with CBR2/NH2-NpLH2 (730 nm) due to the bioluminescence recorded when AkaLumine-HCl is used
(Hall et al., 2018; Zambito et al., 2020). Another limitation is that sequential substrate administration re-
quires longer imaging sessions (Kleinovink et al., 2019; Yeh et al., 2019). Indeed, injection of two sub-
strates requires the clearance of the first substrate but provides maximal light emission for each lucif-
erase, thereby reducing spectral interference from each luciferase. Finally, we envision a highly
sensitive triple color BLI application with CBG2/CBR2 with NH2-NpLH2 (680 nm and 720 nm, respectively)
coupled with the novel optimized NanoLuc/hydrofurimazine (460 nm) in the same animal model (Su et al.,
2020). This system (i.e., tri-plex BLI) could be used to visualize localization, activation, and other functional
states of immune cells. In conclusion, a novel dual-color BLI in the NIR window can be accessed using
CBG2 and CBR2 cells treated with a single substrate, NH2-NpLH2. This represents a promising approach
for simultaneous visualization and quantification of two cell populations in deep tissue and in the same
animal model. Collectively, this work will contribute to expand the toolset for in vivo multicolor biolumi-
nescence imaging.Limitations of the study
The size and the photon flux of the signal area in deep tissue represent a potential limitation in the ability to
efficiently separate and quantify the contribution of each luciferase. Although we demonstrated feasibility
for lung imaging, we expect the method to be more accurate for dual color imaging of small areas (e.g.,
lymph nodes and depots of injected cells in deep organs) as demonstrated previously (Branchini et al.,
2007). The kinetics of light emission after i.p. administration of NH2-NpLH2 is slow (BL signals peaking at
20 min), so repeated administration of substrate and imaging must be delayed by approximately 3 h.
When CBG2/NH2-NpLH2 and Akaluc/AkaLumine-HCl are used for multiplex imaging, sequential adminis-
tration of the two substrates is needed. This may require longer imaging sessions depending on substrate
properties as solubility, enzyme affinity, different bio-distribution, and serum stability (Yeh et al., 2019).Resource availability
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Figure S1. In vitro characterization of click beetle luciferase variants, Related to Figure 1. (a) 
Live HEK293T cell lines were transfected with plasmids expressing CBR2, CBG2, CBG99 or 
CBG99opt luciferase genes. Photon fluxes were quantified after treatment with NH2-NpLH2 
substrate (1mM) by the IVIS imager. Spectral curves were built by Living image software 4.5 (Perkin 
Elmer). (b) Vmax and Km parameters of the CBG99opt, CBG2 and CBR2 enzymes with titrated D-




Figure S2. In vitro measurements of the photon fluxes and two-population luciferase brightness 
test. Related to Figure 2. (a) Live HEK293T cells stably expressing Luc2, CBR2, CBG2 and Akaluc 
luciferases, were tested for their brightness after addition of 0.1 mM (left panel) and 1 mM (right 
panel) of D-LH2 or analogues. Quantifications were performed 10 min after substrate addition. BL 
signals were compared to the brightness of CBG2 and statistical analysis was performed by One-way 
ANOVA, p<000.1. Experiment was performed in triplicate (n=3 samples). Error bars represent ±SD. 
b) In vitro two-population dual-color imaging of transfected HEK293T cells expressing CBR2 or/and 




Click beetle mutant construction. CBG99 and CBR wild type were codon optimized to match the 
codon usage in CBR2. Substitutions known to red shift CBG99 were added to the codon optimized 
CBG99 template, while substitutions known to blue shift CBR were added to the codon optimized 
CBR template. Substitutions of interest were combined on a common template to arrive at CBG2. 
Plasmids were constructed by Gene Dynamics, LLC.  
 
Screening of luciferase mutants in live and lytic cell assay 
Media was aspirated from a confluent flask of HEK293 cells (ATCC Hek293 cell (CRL1573). Cells 
were washed with DPBS (10 ml) (Life Technologies 14190) and then detached from the flask with 
TrypLE Express Trypsin (3 ml) (Life Technologies (12604).  Cells were counted and resuspended to 
a concentration of 100,000 cell ml-1 in DMEM media supplemented with FBS (10%) and then diluted 
cells (100 μl) of was added to each well of a 96 well assay plate. Plates were grown for 24 h at 37 °C 
with 5% CO2. The following day transfection complexes were prepared for each construct (CBGopt, 
CBR2, CBG2) which consisted of DNA (1 μg) diluted in a final volume of OptiMEM (50 μl) (11058) 
with Fugene transfection reagent (3.3 μl) (Promega E2311).  Transfection complexes were incubated 
(15 min) and then each complex (5 μl) was added to wells of assay plates for each sample. Samples 
were then incubated for an additional (24 h).  The following day both lytic and live cell assays were 
performed on each sample.  For the live cell readings substrates were titrated as described below for 
Km and RLUmax determination.  For the lytic reading BrightGlo assay buffer (Promega E264B) 
supplemented with ATP (1 mM) and D-Luciferin (100 μM) or NH2-NpLH2 (100 μM) was added to 
4 wells for each sample. Plates were placed on an orbital shaker at 600 RPM for 3 or 10 min and then 
luminescence was measured on a GMM+ GloMax® Multi+ for D-Luciferin or LAS 4000 CCD 
imager for NH2-NpLH2. 
 
Enzyme characterization: Km and RLUmax determination 
The following substrate solutions were prepared in DPBS: D-LH2 (30 mM) (Promega), NH2-NpLH2 
(8 mM). Two-fold serial dilutions were prepared for each substrate (30 mM to 0.93 mM for D-LH2 
or 8 mM to 0.25 mM for NH2-NpLH2). Prior to assay, media from transfected wells was aspirated 
and replaced with CO2 independent media supplemented with FBS (10%). Substrate dilutions (30 µl) 
were added to cells transfected with either CBGopt, CBG2 and CBR2. The plate was manually 
shaken, and immediately placed in a GloMax®-Multi+ luminometer (Promega) set to 37 °C. Kinetic 
reads were obtained for each substrate and sample combination.  Initial timepoints were used to 
determine Km and RLUmax for each substrate. Km and RLUmax values were calculated using 
GraphPad Prism (Michaelis–Menten regression). 
 
Cell culture and Preparation for cell assays 
HEK293T cells were grown in DMEM medium (Sigma, St. Louis, Mo, USA) supplemented with 
FBS (10%) and of penicillin (1%) and streptomycin (1%) and incubated at 37 °C with 5% CO2. When 
cell confluence reached around 80%, cells were washed with DPBS (life technologies 14190) and 
detached with 1 ml of Trypsin. Cells were centrifuged and re-suspended with fresh new medium (8 
ml). Cell counting was performed using BioRad TC20 cell counter.  
 
Cell transfection  
HEK293T were plated at the density of 2 x 104 cells per well in a black 96 well plate (100 µl of 
complete DMEM). DNA plasmid of each luciferases (LUC2, CBG2, CBR2 or CBRopt) was diluted 
(at the concentration of 0.020 µg µl-1 in 16 µl of sterile deionized water) to transfect 3 wells. Fugene® 
HD reagent (1 µl) was added to the complex and after mixing carefully, it was incubated for 10 min 
at room temperature. the preparation (5 µl) was added to each well of previously plated HEK293T. 
Plate was incubated at 37 ºC with 5% of CO2 for 24 h.  
 
Lentiviral production 
Virus production and cell transduction were performed under appropriate biosafety level conditions 
(ML‐II) in accordance with the National Biosafety Guidelines and Regulations for Research on 
Genetically Modified Organisms. Procedures and protocols were reviewed and approved by the EMC 
Biosafety Committee (GMO permit 99-163). The lentiviral plasmids pCDH-EF1-CBG2-T2A-
copGFP, pCDH-EF1-CBR2-T2A-copGFP were used to transfect HEK‐293 T cells with three 
packaging plasmids (pCMV‐VSVG, pMDLg‐RRE, pRSV‐REV; Addgene, Cambridge, MA, USA) 
and the lentiviral vector plasmids using PEI transfection reagent (1mg/ml)/µg DNA) as previously 
described (Mezzanotte et al. 2011). The supernatant containing lentiviral particles were collected 48 
h and 72 h after infection. Subsequent quantification of the virus was performed using a standard 
antigen‐capture HIV p24 ELISA (ZeptoMetrix Corporation, NY, USA). Lentiviral plasmid of pCDH-
EF1-Akaluc-T2A-copGFP was produced as previously described (Zambito et al. 2020). 
 
Cell transduction  
Cell transduction was performed by culturing HEK293T cells in complete DMEM at the density of 
200,000 cells in a T25-flask with medium (5 ml). Expression in the lentiviral plasmid is driven by 
housekeeping elongation factor 1α (EF1) promoter. Cells were transduced with MOI 1 of either 
pCDH-EF1-CBG2-T2A-copGFP, pCDH-EF1-CBR2-T2A-copGFP with Polybrene (hexametride 
bromide, Sigma-Aldrich) at the final concentration (8 µg ml-1). Cell were then expanded and sorted 
two times for copGFP (copepod Potenilla plumata) expression by FACS (BD-FACS AriaIII, BD 
Biosciences). HEK293T cells were transduced with pCDH-EF1-Akaluc-T2A-copGFP as previously 
described (Zambito et al. 2020). 
 
In vitro bioluminescence imaging  
For in vitro BL imaging, HEK293T cells were plated at a density of 1 x 104 cells per well in a black 
96-well plate (Greiner Cell Star®). Cells were transfected with DNA plasmids of CBG2, CBR2 or 
simultaneously transfected with both plasmids. Prior imaging session, cells were washed and 
resuspended in PBS.  
For the other tests with HEK-EF1-CBG2-T2A-copGFP, HEK-EF1-CBR2-T2A-copGFP and HEK-
EF1-Akaluc-T2A-copGFP, cells were plated in triplicate in a black 96-well plate at the density of 1 
x 104 cells per well and incubated at 37 °C for 24 h. Prior imaging session, cells were washed and 
resuspended in PBS. For kinetic study of HEK-EF1-CBG2-T2A-copGFP and HEK-EF1-CBR2-T2A-
copGFP, imaging was performed after addition of NH2-NpLH2 (final concentration 0.1 mM). 
Imaging settings were made at the IVIS spectrum system with open filter, 30 s exposure time, FOV 
C, f/stop=1, medium binning. Imaging acquisitions were made every 2 min for a total of 15 
acquisitions. This experiment was performed in triplicate. For all other in vitro measurements, 
imaging was performed after addition of D-LH2, NH2-NpLH2 or Akalumine-HCl (final 
concentration of 1 mM resuspended in PBS; 100 µl per well of a 96 black well plate). To accurately 
measure photon output while taking the kinetic profiles into account, images were acquired 10 min 
after addition of D-LH2 or NH2-NpLH2 substrates and 5 min after addition of the Akalumine-HCl 
substrate. Images were acquired with the following settings: FOV C, f/stop=1, medium binning, 30 s 
exposure time and open filter. Images were acquired selecting a series of band pass filters ranged 
from 540 nm to 800 nm on the IVIS Spectrum (20 nm bandpass from 560 nm to 800 nm). ROI 
analysis of the spectral profiles and spectral unmixing were made on Living image software 4.5 
(Perkin Elmer).  
For spectral unmixing analysis, guided spectral unmixing of pure (100%) HEK-CBG2 cells, HEK-
CBR2 or HEK-Akaluc cells was created. This allowed us to obtain a specific library of spectra for 
each luciferase and a distinct spectral signature for each luciferase/substrate. The specific library of 
spectra was then used to perform the spectral unmixing on a mixture of cell populations. Therefore, 
the relevant library of spectra allowed us to quantify the photons derived from the mixed cell 
population and to distinguish contributions from HEK-CBG2, HEK CBR2 or HEK-Akaluc. The 
spectral unmixing allowed also to draw respective spectral profiles for HEK-CBG2, HEK-CBR2 and 
HEK-Akaluc. Experiments were repeated three times with three replicates. 
 
In vivo animal model 
Animal studies were approved by the Ethical Committee of Erasmus Medical Center, Rotterdam, The 
Netherlands. Animal care and handling was in accordance with the guidelines and regulations as 
stipulated by the Dutch Experiments on animal act (WoD) and The European Directive in the 
protection on animal used for scientific purposes (2010/63/EU). BALB/C nude (females) were 
purchased from Charles River Laboratory (The Netherlands). All mice aged 6‒10 weeks were 
provided access to food and water ad libitum and were hosted in the animal facility at the Erasmus 
MC, Rotterdam, The Netherlands. 
 
In vivo bioluminescence imaging: dual-color imaging, spectral unmixing and sequential 
imaging 
Animal experiments were performed with mice anesthetized using isoflurane (1.5%). Groups of 3 
mice were used for each condition. For the deep tissue model, HEK-EF1-CBG2-T2A-copGFP and 
HEK-EF1-CBR2-T2A-copGFP, HEK-EF1-Akaluc-T2A-copGFP were injected intravenously (i.v.) 
at a density of 1 million cells in 100 µl DPBS. NH2-NpLH2 (220 mg Kg-1) or Akalumine-HCl (50 
mg Kg-1) substrates were injected intraperitoneally (i.p.) (200 µl). In the case where animals received 
50/50, 75/25 or 25/75 ratio of HEK-EF1-CBG2-T2A-copGFP and HEK-EF1-CBR2-T2A-copGFP, 
5x105/5x105, 7.5x105/2.5x105 and 2.5x105/7.5x105 cells were i.v. injected. 
The dose of NH2-NpLH2 or Akalumine-HCl substrates injected intraperitoneally were calculated 
based on the maximum solubility (especially for Akalumine-HCl), tolerability in mice and maximum 
attainable signal on previous findings (Branchini et al. 2010; Gammon et al. 2006). Images were 
acquired by IVIS spectrum (FOV C, binning medium, f/stop=1, 20 nm). Band pass filters were ranged 
between 540 nm to 800 nm and exposure time of 30 s was optimal for quantification of 
bioluminescent signals required by spectral unmixing.). The series of images acquired with filters 
were taken 10, 16, and 21 min after i.p. injection of the substrates to determine the timing for maximal 
signal output.  The stage was heated to 37 ºC. Open filters were used prior to the spectral recordings 
to assess stability of the substrate.  
Spectral analysis and spectral unmixing of the in vivo images were performed by drawing ROIs with 
Living image software (Perkin Elmer). For guided spectral unmixing pure CBG2, CBR2 and Akaluc 
bioluminescent signals were recorded when combined with appropriate substrate. Once pure libraries 
were built, the relevant library spectra were then used to distinguish each luciferase contributions by 
spectral unmixing in the lung model. The spectral properties for each luciferase were drawn and 
quantified using the spectral unmixing algorithm. 
For sequential imaging of HEK-CBG2 and HEK-Akaluc, mice were first injected with HEK-CBG2 
cells (1x106) i.v. To quantify the bioluminescent signal required by spectral unmixing, the imaging 
session started 15 min after i.p. injection of NH2-NpLH2 (220 mg Kg-1) using band pass filters that 
ranged between 540 nm to 800 nm with an exposure time of 30 s.  Once the imaging session for HEK-
CBG2/ NH2-NpLH2 was completed, clearance of the substrate was monitored after approximately 4 
h by performing a pre-scan to access the absence of the signal. Then, HEK-Akaluc cells were injected 
i.v. (1x106) and Akalumine-HCl i.p. (50 mg Kg-1). Images were acquired 5 min after substrate 
addition using band pass filters that ranged between 540 nm to 800 nm with exposure time of 30 s. 
Bioluminescent signals were quantified by spectral unmixing. All mice were culled at the end of the 
in vivo imaging sessions. 
Statistical analysis  
Km and RLUmax values were calculated using GraphPad Prism (Michaelis–Menten regression). The 
other in vitro and in vivo tests were performed using Graphpad 7 software and T test and ONE-way 
ANOVA. Results reported as mean ±SD and significance attributed when p< 0.001 (*) for in vitro 
tests or p< 0.05 (*) for in vivo tests. 
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